Summary

  • Physicians must adhere to specific federal and state DEA medical recordkeeping requirements in their office-based buprenorphine practice; some requirements go beyond standard Schedule III requirements
  • Physicians who wish to dispense buprenorphine from their office must adhere to strict federal recordkeeping guidelines.
  • All prescriptions for buprenorphine should have your U.S. DEA number plus the “X” DEA number (which denotes buprenorphine prescriber status) written on them or the pharmacy may not fill it. You must receive permission from the patient before you can fax the prescription to a pharmacy
  • The Drug Enforcement Administration (DEA) conducts unscheduled audits of buprenorphine practices each year for a small minority of practices, but has the right to inspect practices at any time.
  • In addition to standard HIPAA laws, federal regulations mandate strict confidentiality for information about patients being treated for substance use disorders, including written consent before disclosing information to any other source.
  • In addition to the above, detailed documentation should include history and current status; treatment plan; induction, maintenance, discontinuation, and discharge information; and payment information